NP Life Sciences Health Industry Group (NP Life Sciences Health Industry Group) Risk Assessment

View and export this data going back to 2020. Start your Free Trial

What is NP Life Sciences Health Industry Group Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of NP Life Sciences Health Industry Group is: No Data: Cannot be evaluated.

Competitive Comparison of NP Life Sciences Health Industry Group's Risk Assessment

For the Education & Training Services subindustry, NP Life Sciences Health Industry Group's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

NP Life Sciences Health Industry Group's Risk Assessment Distribution in the Education Industry

For the Education industry and Consumer Defensive sector, NP Life Sciences Health Industry Group's Risk Assessment distribution charts can be found below:

* The bar in red indicates where NP Life Sciences Health Industry Group's Risk Assessment falls into.

NP Life Sciences Health Industry Group (OTCPK:NPLS) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

NP Life Sciences Health Industry Group Risk Assessment Related Terms

Thank you for viewing the detailed overview of NP Life Sciences Health Industry Group's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

NP Life Sciences Health Industry Group (NP Life Sciences Health Industry Group) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Education » NP Life Sciences Health Industry Group Inc (OTCPK:NPLS) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

N/A

Address

4125 Blackhawk Plaza Circle, Suite 166, Danville, CA, USA, 94506

Website

https://www.gjcc.us

NP Life Sciences Health Industry Group Inc offers international study tours, online and offline, in classical Chinese studies through classes, lectures, cultural, and artistic events. Its revenues are comprised of providing promotions and consulting services to its partner who gives international study tour services, commission to be received from partner enrollment services and mental health consulting services.

Executives

Guidong Wang	director, 10 percent owner, officer: Chairman, CEO. Pres, Treas	4125 BLACKHAWK PLAZA CIRCLE, SUITE 168, DANVILLE CA 94506
Huaying Zhu	director, officer: Secretary	4125 BLACKHAWK PLAZA CIRCLE, SUITE 168, DANVILLE CA 94506
Jonathan Ginsberg	director	4125 BLACKHAWK PLAZA CIRCLE, SUITE 166, DANVILLE CA 94506
Sanjun Kuang	director, officer: CEO, President and Treasurer	4125 BLACKHAWK PLAZA CIRCLE, SUITE 166, DANVILLE CA 94506
Meisang Hu	director, 10 percent owner	4125 BLACKHAWK PLAZA CIRCLE, SUITE 166, DANVILLE CA 94506
Huawei Li	director, officer: Secretary	4125 BLACKHAWK PLAZA CIRCLE, SUITE 166, DANVILLE CA 94506
Jianhua Wang	10 percent owner	4125 BLACKHAWK PLAZA CIRCLE, SUITE 166, DANVILLE CA 94506

NP Life Sciences Health Industry Group (NP Life Sciences Health Industry Group) Headlines

No Headlines